Risk Factors for the Presence and Progression of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark
The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the course of cardiovascular autonomic neuropathy (CAN) and related cardiometabolic risk factors in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: CAN and cardiometabolic risk factors were assessed in the Danish arm of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Denmark) at 6-year (n = 777) and 13-year (n = 443) follow-up examinations. Cardiovascular autonomic reflex tests (CARTs)—that is, lying to standing, deep breathing, and the Valsalva maneuver—and 2-min resting heart rate variability (HRV) indices were obtained as the main measures of CAN. Risk factors related to CAN status, as determined by CARTs, were studied by using multivariate logistic regressions. The effects of risk factors on continuous CARTs and HRV indices, and their changes over time, were estimated in linear mixed models. RESULTS: A progressive yet heterogeneous course of CAN occurred between the 6- and 13-year follow-ups. Higher HbA1c, weight, BMI, and triglycerides were associated with prevalent CAN. No significant effect of risk factors on CARTs was found when they were analyzed as continuous variables. CART indices decreased over time, and a trend of decreasing HRV indices was seen. Higher HbA1c and BMI were associated with lower HRV index values, but these differences diminished over time. CONCLUSIONS: These data confirm that hyperglycemia, obesity, and hypertriglyceridemia are negatively related to indices of CAN, although these effects diminish over time. The observed heterogeneous course of CAN may challenge the present clinical approach of categorically classifying CARTs to diagnose CAN and the notion of CAN being irreversible.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetic macular edema in the absence of proliferative retinopathy is most commonly treated with repeated anti-VEGF injections.541”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [541]
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use
Electrophysiology, T. F. O. T. E. S. O. C. T. N. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.1043 · Cited by 17,159
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“No clear evidence supports glucoselowering intervention to prevent CAN in type 2 diabetes (14,15).”
BackgroundTesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602 · cited 5×
“Albuminuria was associated with CAN at the 6-year follow-up, which is in line with previous research (1).”
BackgroundResultInfluentialSelf-citationThe Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434
Diabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255
Gæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981 · cited 5×
“opment of CAN among participants with type 2 diabetes and albuminuria who received similar treatment (16).”
BackgroundResultInfluentialSpallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957
Self-citationMaser, R. E., Mitchell, B. D., Vinik, A. I., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1895 · Cited by 578
Research works printed but not linked: 2
- Cardone, 1990, I test che valutano la risposta riflessa cardiovascolare. Neuropatia diabetica, Rassegna Bibliografica, 2, 151
- Pop-Busui, 2017, Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study, 94
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationSpallone, V. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0259 · Cited by 295
“tes in Primary Care (ADDITION) study, 299 patients were evaluated for CAN at 6 and 13 years [27].”
BackgroundInfluentialPicard, M., Tauveron, I., Magdasy, S., Benichou, T., Bagheri, R., Ugbolue, U. C., Navel, V., & Dutheil, F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251863 · Cited by 130
Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management
Eleftheriadou, A., Spallone, V., Tahrani, A. A., & Alam, U. (2024) · Diabetologia · doi:10.1007/s00125-024-06242-0 · Cited by 123
CrossTalk proposal: Heart rate variability is a valid measure of cardiac autonomic responsiveness
Malík, M., Hnatkova, K., Huikuri, H. V., Lombardi, F., Schmidt, G. P., & Zabel, M. (2019) · The Journal of Physiology · doi:10.1113/jp277500 · Cited by 108
“Numerous publications showed the clinical value of HRV in the early detection and type-classification of diabetic neuropathy (Howorka et al. 1998; Osterhues et al. 1998; Jirkovská et al. 2006; Andersen et al. 2018).”
BackgroundGuo, Q., Zang, P., Xu, S., Song, W., Zhang, Z., Liu, C., Guo, Z., Chen, J., Lu, B., Gu, P., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5817074 · Cited by 74
“At present, most studies demonstrated that HbA1c was a risk factor for the presence and progression of CAN [15].”
BackgroundLipids and peripheral neuropathy
Iqbal, Z., Bashir, B., Ferdousi, M., Kalteniece, A., Alam, U., Malik, R. A., & Soran, H. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000770 · Cited by 80
“In the ADDITION study, obesity, hyperglycaemia and hypertriglyceridaemia were associated with prevalent CAN whereas high LDL-C was found to be protective against CAN at 6 years [82], but this effect was lost after 13 years of follow up [82].”
BackgroundKatsiki, N., Anagnostis, P. G., Kotsa, K., Goulis, D. G., & Mikhailidis, D. P. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190708192134 · Cited by 73
Tang, Y., Shah, H., Bueno Junior, C. R., Sun, X., Mitri, J., Sambataro, M., Sambado, L., Gerstein, H. C., Fonseca, V., Doria, A., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1842 · Cited by 60
“A negative CVD history identifies T2D patients who especially benefit from intensive glycemic control for CAN prevention.”
BackgroundInfluentialSelf-citationThe conundrum of diabetic neuropathies—Past, present, and future
Ang, L. P., Mizokami‐Stout, K., Eid, S., Elafros, M. A., Callaghan, B. C., Feldman, E. L., & Pop‐Busui, R. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108334 · Cited by 66
Self-citationCardiovascular autonomic neuropathy: A silent killer with long reach
Ang, L., Dillon, B., Mizokami-Stout, K., & Pop-Busui, R. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102646 · Cited by 53
Self-citationOh, T. J., Lee, J.-E., Choi, S. H., & Jang, H. C. (2019) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2019.28.2.112 · Cited by 59
Himeno, T., Kamiya, H., & Nakamura, J. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13173 · Cited by 54
Magnetic Resonance Neurography: Improved Diagnosis of Peripheral Neuropathies
Kollmer, J., & Bendszus, M. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01166-8 · Cited by 47
Ziegler, D., Strom, A., Straßburger, K., Knebel, B., Bönhof, G. J., Kotzka, J., Szendroedi, J., Roden, M., & for the German Diabetes Study group (2020) · Diabetologia · doi:10.1007/s00125-020-05310-5 · Cited by 40
“Cardiovascular autonomic function tests were performed to diagnose CAN, including seven HRV indices measured during spontaneous breathing over 5 min (coefficient of R–”
BackgroundInfluentialBhati, P., Alam, R., Moiz, J. A., & Hussain, M. E. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00435-w · Cited by 39
Azmi, S., Ferdousi, M., Liu, Y., Adam, S., Siahmansur, T. J., Ponirakis, G., Marshall, A. G., Petropoulos, I. N., Ho, J. H., Syed, A. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90346-9 · Cited by 28
Bönhof, G. J., Herder, C., & Ziegler, D. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210412123740 · Cited by 29
Davis, T. M. E., Tan, E., & Davis, W. A. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02185-3 · Cited by 24
“In a recent narrative review, the prevalence of CAN in type 2 diabetes was reported as between 31 and 73% [3], but a subsequent Danish primary care study found a much lower prevalence of 9% after 6 years of screening-detected diabetes [4].”
BackgroundResultInfluentialAutonomic diabetic neuropathies: A brief overview
Pop‐Busui, R. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110762 · Cited by 29
Self-citationLiu, Y., Yu, P., Jin, J., Chen, Y., Chen, C., Chen, Z., Huang, H., & Xu, L. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13507 · Cited by 21
Diabetes and Metabolic Disorders and the Peripheral Nervous System
Gibbons, C. H. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000906 · Cited by 24
Hansen, C. S., Lundby-Christiansen, L., Tarnow, L., Gluud, C. N., Hedetoft, C., Thorsteinsson, B., Hemmingsen, B., Wiinberg, N., Sneppen, S. B., Lund, S. S., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01131-3 · Cited by 21
“An possible autonomic component of these changes may be reversible as autonomic dysfunction may be reversible in some cases [44, 45].”
BackgroundSelf-citationKlinge, M. W., Sutter, N., Mark, E. B., Haase, A., Borghammer, P., Schlageter, V., Lund, S. A., Fleischer, J., Knudsen, K., Drewes, A. M., et al. (2021) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19195 · Cited by 19
“121 Volume of fluid in the stomach 31 (17-56) 37 (24-84) 0.”
Self-citationAutonomic dysfunction in patients with COVID‑19
Erdal, Y., Atalar, A. Ç., Güneş, T., Okluoglu, T., Yavuz, N., & Emre, U. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-022-01899-z · Cited by 20
“Hightened sympathetic nervous system activity accompanies chronic cardiovascular and endocrine diseases such as hypertension, cardiac failure, type 2 diabetes mellitus and chronic renal failure and contributes to the progression of these diseases [44].”
BackgroundLipids, lipid-lowering therapy, and neuropathy: a narrative review
Pasha, R., Azmi, S., Ferdousi, M., Kalteniece, A., Bashir, B., Gouni-Berthold, I., Malik, R. A., & Soran, H. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.03.013 · Cited by 18
D’Onofrio, L., Ferdousi, M., Kalteniece, A., Iqbal, Z., Petropoulos, I. N., Ponirakis, G., Buzzetti, R., Malik, R. A., & Soran, H. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.04.006 · Cited by 18
Hansen, C. S., Suvitaival, T., Theilade, S., Mattila, I. M., Lajer, M., Trôst, K., Ahonen, L. L., Hansen, T. W., Legido‐Quigley, C., Rossing, P. R., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.831793 · Cited by 19
“Also, hyperlipidemia seen as elevated triglycerides is a known risk factor for CAN (2).”
BackgroundThe Epidemiology of Diabetic Neuropathy
Hansen, C. S., Määttä, L. L., Andersen, S. T., & Charles, M. H. (2023) · Contemporary Diabetes · doi:10.1007/978-3-031-15613-7_2 · Cited by 17
Self-citationJun, J. E., Lee, S.-E., Choi, M. S., Park, S. W., Hwang, Y., & Kim, J. H. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0830-4 · Cited by 20
Preferential impairment of parasympathetic autonomic function in type 2 diabetes
Rasmussen, T. K., Finnerup, N. B., Singer, W., Jensen, T. S., Hansen, J., & Terkelsen, A. J. (2022) · Autonomic Neuroscience · doi:10.1016/j.autneu.2022.103026 · Cited by 18
“…subjects, despite unfavorable clinical profiles (higher BMI and higher BP) associated with the development of cardiovascular autonomic neuropathy (Andersen et al., 2018), as well as significant parasympathetic impairment and a higher Utah Early Neuropathy score, indicative of small fiber…”
Self-citationHadad, R., Larsen, B. S., Weber, P., Stavnem, D. M., Kristiansen, O. P., Nielsen, O. W., Haugaard, S. B., & Sajadieh, A. (2021) · Diabetic Medicine · doi:10.1111/dme.14559 · Cited by 17
“Exclusion criteria were as follows: (1) manifest ischaemic heart disease, for example, a history of acute myocardial infarction, coronary revascularization and angina pectoris; (2) other manifest cardiac diseases, for example, congestive heart failure, valvular heart disease including atrial fibrillation or medical tr…”
BackgroundHansen, C. S., Christensen, M. M. B., Vistisen, D., Jepsen, R., Ellervik, C., Jørgensen, M. E., & Fleischer, J. (2024) · Clinical Autonomic Research · doi:10.1007/s10286-024-01069-6 · Cited by 13
“The device has been described in detail previously [22–25].”
Self-citationBarzilay, J. I., Ghosh, A., Pop‐Busui, R., Ahmann, A., Balasubramanyam, A., Banerji, M. A., Cohen, R. M., Green, J., Ismail‐Beigi, F., Martin, C. L., et al. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108047 · Cited by 13
Self-citationCardiac autonomic neuropathy in nonobese young adults with type 1 diabetes
Kim, H. Y., Jung, H. W., Lee, Y. A., Shin, C. H., & Yang, S. W. (2019) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2019.24.3.180 · Cited by 12
de Matos, M. R., Santos‐Bezerra, D. P., Cavalcante, C. D. G. D., de Carvalho, J. X., Leite, J., Neves, J. A. J., Admoni, S. N., Passarelli, M., Parisi, M. C. R., & Corrêa‐Giannella, M. L. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17093232 · Cited by 12
“3%) [19] and Denmark (9% and 15% in two different time points, seven years apart) [20], although the diagnosis was performed using different criteria.”
Felício, J. S., de Moraes, L. V., Lemos, G., de Souza, Í. J. A., Vieira, G. C., Silva, L. D. S. D., de Queiroz, N. N. M., Souza, A. C., de Melo, F. T. C., Neto, J. F. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-56934-1 · Cited by 10
“In addition to the known factors in the development and progression of CAN, such as diabetes duration and glycemic control, other aspects have been investigated 56,57 .”
BackgroundInfluentialJeyaseeli, A., Ganesan, R., Mathivanan, D., & Prabagaran, A. (2023) · Cureus · doi:10.7759/cureus.42541 · Cited by 10
“CAN increases cardiovascular mortality and morbidity in T2DM patients [7], while the risk factors for the development of CAN in T2DM patients are hyperglycemia, obesity and hypertriglyceridemia [9].”
BackgroundWu, B., Sheng, X., Xu, Z., Zhang, Y., Yu, D., Guo, J., Peng, H. Y., Liang, S., & Li, G. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.01.017 · Cited by 10
Jung, C., Cho, Y. Y., Choi, D., Kim, B., Jung, S.-H., Kim, C., & Mok, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-74390-9 · Cited by 10
“The established 9,11,36 .”
Autonomic neuropathy in diabetes
Tannus, L. R. M., & Cobas, R. A. (2026) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2025-0406 · Cited by 15
“In the SEARCH study (13), prevalence was 12% in youth with type 1 diabetes (T1D), and 17% in those with T2D, higher than in ADDITION study (11), partly due to methodological differences in CAN assessment.”
InfluentialNormative data on cardiovascular autonomic function in Greenlandic Inuit
Christensen, M. M. B., Hansen, C. S., Fleischer, J., Vistisen, D., Byberg, S., Larsen, T. J., Laursen, J. C., & Jørgensen, M. E. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002121 · Cited by 9
Self-citationMenduni, M., D’Amato, C., Leoni, M., Izzo, V., Staltari, M., Greco, C., Abbatepassero, A., Seminara, G., D’Ippolito, I., Lauro, D., et al. (2022) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12510 · Cited by 10
Cardoso, C. R. L., de Oliveira, V. A. G., Leite, N. C., & Salles, G. F. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110232 · Cited by 8
Dhillon, S., Fithrie, A., & Batubara, C. A. (2023) · Journal of Society Medicine · doi:10.47353/jsocmed.v2i4.47 · Cited by 11
Lilleberg, H. S., Cichosz, S. L., Svensson, M., Christensen, J. H., Fleischer, J., Eide, I. A., & Jenssen, T. G. (2019) · Nutrients · doi:10.3390/nu11122847 · Cited by 10
“The tests were performed by laboratory technicians using a VagusTM (Medicus Engineering, Aarhus, Denmark) [23].”
MethodSelf-citationLaursen, J. C., Rasmussen, I. K. B., Zobel, E. H., Hasbak, P., von Scholten, B. J., Holmvang, L., Ripa, R. S., Hansen, C. S., Frimodt‐Møller, M., Kjær, A., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.780679 · Cited by 8
Schaarup, J. R., Bjerg, L., Hansen, C. S., Grove, E. L., Andersen, S. T., Vistisen, D., Brage, S., Sandbæk, A., & Witte, D. R. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16566 · Cited by 8
“Recordings of long-term HRV are both influenced by habitual physical activity and actual physical activity during the measurement of HRV. 11,31 Participants in ADDITION-PRO generally had low physical activity levels during the multiday recording.”
InfluentialSelf-citationBhati, P., & Hussain, M. E. (2021) · Journal of Physical Activity and Health · doi:10.1123/jpah.2020-0194 · Cited by 7
Li, L., Du, J., Liu, S., Yang, R., Xu, X., Yang, Y., Ma, X., Li, G., Liu, S., Li, G., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110044 · Cited by 7
Okdahl, T., Wegeberg, A., Jensen, M. M., Quist, J. S., & Brock, C. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01834-1 · Cited by 6
“Currently, the best treatment option for CAN is haltering progression by early recognition, lifestyle changes, and high-intensity glucose-lowering treatments [4, 5, 6].”
InfluentialFu, X., Liu, Q., Pan, Q., Peng, R., Huang, Z., Guo, X., Tan, M., Li, Q., Jia, L., Li, Y., et al. (2025) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2025-0013 · Cited by 6
“[10,18] During the tests, the participants were instructed to keep quiet and stay awake.”
Intensive Glycemic Therapy in Type 2 Diabetes Patients With Cardiac Autonomic Dysfunction
Huang, Y., Xie, P., Zhang, S., Liu, M., Huang, R., Xiong, Z., Zhong, X., Lin, Y., Zhou, Z., Zhang, W., et al. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.03.020 · Cited by 6
Huang, Y., Chen, H., Hu, D., & Wan, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.921287 · Cited by 6
FRACTAL DIMENSION TECHNIQUES FOR ANALYSIS OF CARDIAC AUTONOMIC NEUROPATHY (CAN)
Sharanya, S., & Arjunan, S. P. (2023) · Biomedical Engineering Applications Basis and Communications · doi:10.4015/s1016237223500035 · Cited by 6
Peters, E., Itani, M., Kristensen, A. G., Terkelsen, A. J., Krøigård, T., Tankişi, H., Jensen, T. S., Finnerup, N. B., & Gylfadottir, S. S. (2023) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12580 · Cited by 6
“Strong opioids, n (%) 9 (13) 4 (11) 7 (23) 0.”
Self-citationPhilimon, S. P., & Huong, A. K. C. (2021) · IEEE Access · doi:10.1109/access.2021.3055221 · Cited by 6
“control, whichmay also be the risk-factors of diabetes-related neuropathy that affect the healing progress [43].”
BackgroundZhou, H., Huang, Y., Xie, P., Zhang, S., Liu, M., Xiong, Z., Huang, R., Xu, X., Li, M., Zhou, Z., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.035788 · Cited by 5
“9,11,12,23 An important question that arises is whether intensive glycemic treatment mitigates the cardiovascular and mortality risk associated with CAN.”
Ramírez-Villalobos, D., Monterrubio‐Flores, E., Márquez, M. F., Rabanal, J. E. A., Shamah‐Levy, T., Perichart‐Perera, O., Macías, N., & Campos‐Nonato, I. (2025) · Nutrients · doi:10.3390/nu17223535 · Cited by 6
“Multiple pathways link T2D to CVD, including hyperglycemia-related atherosclerosis, inflammation, diabetic cardiomyopathy [45], microvascular endothelial dysfunction, cytokine release, and cellular hypoxia.”
Comprehensive Factors for Predicting the Complications of Diabetes Mellitus: A Systematic Review
Erandathi, M., Wang, W. Y. C., Mayo, M., & Lee, C. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998271863231116062601 · Cited by 8
“No effect modification has been found with the sex disparity among patients with cardiovascular autonomic neuropathy [71].”
BackgroundReply to: Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19
Lim, S. K., Bae, J. H., Kwon, H., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00467-4 · Cited by 5
Poulsen, M. B., Julu, P. O. O., Røikjer, J., Drewes, A. M., & Brock, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1653881 · Cited by 4
Serhiyenko, V. A., Hotsko, M. E., Markevich, Y., Markevich, M. P., Sehin, V. B., Serhiyenko, L. M., & Serhiyenko, A. A. (2023) · Physiology · doi:10.5772/intechopen.112894 · Cited by 5
Wang, J., Xu, Z., Lv, K., Ye, Y., Luo, D., Wan, L., Zhou, F., Yu, A., Wang, S., Liu, J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.864008 · Cited by 5
Blok-Husum, L., Brcelic, M. A. R., Bassi, H. K. F. K., Jensen, S. E., Nielsen, R. E., Kragholm, K. H., Fleischer, J., Laugesen, E., & Polcwiartek, C. (2023) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2023.100252 · Cited by 7
“For the screening of CAN, a handheld instrument Vagus ™ (Medicus Engineering, Aarhus, Denmark) [20] was used.”
MethodSelf-citationDiabetes-associated cardiac autonomic neuropathy
Wooton, A. K., & Melchior, L. M. (2019) · The Nurse Practitioner · doi:10.1097/01.npr.0000651104.30787.7a · Cited by 4
Whole Gut Motility Patterns in Patients with Chronic Nausea and Vomiting
Klinge, M. W., Haase, A., Sutter, N., Krogh, K., Scott, S. M., Schlageter, V., Mark, E. B., Nandhra, G. K., Drewes, A. M., & Loedrup, A. B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237127 · Cited by 3
From glycemic instability to neuropathic risk: a propensity score-matched retrospective cohort study
Yan, C., & Wang, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1766149 · Cited by 3
“A substantial number of patients achieve recommended HbA1c targets yet still develop or experience progression of DPN (7, 8).”
TISSUE OXYGEN LEVEL IN ACUTE AND CHRONIC WOUND: A COMPARISON STUDY
Philimon, S. P., Huong, A. K. C., & Ngu, X. T. I. (2020) · Jurnal Teknologi · doi:10.11113/jt.v82.14418 · Cited by 3
Serhiyenko, V. A., Долинай, М., Sehin, V. B., Lazur, Y. V., & Serhiyenko, A. A. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.20.8.2024.1461 · Cited by 3
Orthostatic Hypotension and Sudomotor Dysfunction in Diabetes
Fanty, L., & Gibbons, C. H. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_26 · Cited by 2
Oluwagbemigun, K., Ziegler, D., Strom, A., Heier, M., Bönhof, G. J., Roden, M., Rathmann, W., Meisinger, C., Peters, A., Hauck, S. M., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.042144 · Cited by 2
“82”
Poulsen, M. B., Okdahl, T., Buciek, J. H., Drewes, A. M., Karlsson, P., Ahluwalia, T. S., Brock, B., Brock, C., Rossing, P. R., & Hansen, C. S. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101074 · Cited by 2
From Beat to Risk: How Heart Rate Variability Predicts Arrhythmias in Type 2 Diabetes
Bobu, A. M., Duca, Ș.-T., Cucu, A. I., Avieriței, D. A., Ponor, C. G., Cepoi, M.-R., Cucută, S., Dmour, B.-A., Costea, C. F., Botnariu, G., et al. (2026) · Life · doi:10.3390/life16030520 · Cited by 2
“…In this context, Anderson et al. demonstrated that cardiac autonomic neuropathy can be partially reversible when diagnosed at an early stage and intensive glycaemic control is implemented promptly, suggesting that early therapeutic intervention can modify the course of autonomic dysfunction [108].”
Diabetic neuropathy: Current issues in diagnosis and prevention
Spallone, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00016-6 · Cited by 2
Cardiovascular Autonomic Neuropathy
Ang, L. P., & Pop‐Busui, R. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_12 · Cited by 2
Self-citationPappa, A., Häusler, M., Tittel, S. R., Boettcher, C., Hilgard, D., Knauer-Fischer, S., Pavel, M., Woelfle, J., & Holl, R. W. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2023-0074 · Cited by 2
A diabeteses cardiovascularis autonóm neuropathia klinikuma, diagnosztikája és terápiája
Kempler, P., & Körei, A. E. (2024) · Orvosi Hetilap · doi:10.1556/650.2024.33027 · Cited by 2
Pop‐Busui, R., Rosin, S. P., Butera, N. M., Krause-Steinrauf, H. J., Assi, H. A., Garg, R., Inzucchi, S. E., Katona, A. M., McGill, J. B., Mudaliar, S. R. D., et al. (2025) · Diabetes Care · doi:10.2337/dc25-1087 · Cited by 2
Self-citationGaneshalingam, A. A., Uhrenholt, N. G., Arnfred, S., Gæde, P., Pedersen, A. K., Bilenberg, N., & Frystyk, J. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-025-00258-0 · Cited by 2
“Importantly, CAN is reversible at the early stages and may improve with weight loss [18, 19].”
InfluentialUPDATE OF CARDIOVASCULAR AUTONOMIC NEUROPATHY IN PATIENTS WITH DIABETES
Universitatea de Medicină și Farmacie „Carol Davila“, B., Nica, A. E., Dobjansch, C., Universitatea de Medicină și Farmacie „Carol Davila“, B., Parlițeanu, O. A., Universitatea de Medicină și Farmacie „Carol Davila“, B., Rusu, E., Universitatea de Medicină și Farmacie „Carol Davila“, B., Radulian, G., & Universitatea de Medicină și Farmacie „Carol Davila“, B. (2021) · Romanian Medical Journal · doi:10.37897/rmj.2021.2.6 · Cited by 1
Morshedizadeh, Z., Ahmadipour, M., & Mahani, S. M. (2022) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/siajr24mvl · Cited by 1
Neuropathy in Type 1 and Type 2 Diabetes
Akıncı, G., Nowacek, D. G., & Callaghan, B. C. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_4 · Cited by 1
Степура, О., Древицька, Т., Im, T., & Zherdova, N. (2024) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2024.2.05 · Cited by 1
Simon, M., Kumlin, S. S., Tawe, B., & Ajee, I. (2024) · OALib · doi:10.4236/oalib.1111747 · Cited by 1
Autonomic responses to postural provocations
Hnatkova, K., & Malík, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817728-0.00015-2
DIAGNOSIS OF THE CARDIAC AUTONOMIC NEUROPATHY IN DIABETIC PATIENT
Shuper, V. О., Shuper, S. V., Rykova, J. O., Trefanenko, I. V., Shumko, G. І., & Reva, Т. V. (2019) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2019.3.12
Diabetische Neuropathie – Relevanz metabolischer Phänotypen
Bönhof, G., & Ziegler, D. (2020) · Der Diabetologe · doi:10.1007/s11428-020-00686-9
“In der ADDITION-DenmarkStudie waren erhöhte Triglyzeridspiegel mit dem Vorliegen einer KAN assoziiert [3].”
BackgroundNew Trends: Time in Range and the Use of Continuous Glucose Monitoring Devices on Glycemic Control
Souza, K. L. V. D., Rassi, M. M. B., de Sá, D. A. R., Bussuan, R. M., Rodrigues, L. C. D. S., & Arbex, A. K. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.1.491 · Cited by 1
Sztanek, F., Jakab, Á. A., Jebelovszki, É., Gaszner, B., Páll, D., Kempler, P., & Harangi, M. (2019) · Diabetologia Hungarica · doi:10.24121/dh.2019.16
“A HbA1c, a testsúly, a testtömegindex mellett a trigliceridszint esetén találtak szignifikáns összefüggést a CAN pervalenciájával, bár időben az összefüggések szorossága változott.(23) Egy másik vizsgálatban 600 diabeteses beteget bevonva azt találták, hogy a T2DM-betegek 44,3%-ában fordult elő CAN, amelynek egyéb koc…”
Körei, A. E., Schnabel, K. K., Tordai, D. Z., Békeffy, M. Z., Gáspár, E. G., Putz, Z., Istenes, I., Tremmel, A., Vági, O. E., Hajdú, N., et al. (2021) · Diabetologia Hungarica · doi:10.24121/dh.2021.5
Cardiac autonomic neuropathy and physical therapy: A case report
Herman, G., Zehr, S., Butts, R., & Dunning, J. R. (2022) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2022.05.013
“The physical therapist should inquire about common symptoms of CAN such as lightheadedness, dizziness, visual impairment, weakness or syncope with standing (Spallone and Ziegler et al., 2011; Andersen et al., 2018; Balcıo glu and Müderriso glu, 2015).”
BackgroundCardiac autonomic neuropathy as risk factor of diabetic complications progression
Салухов, В. В., Zelenina, T. A., Денисович, И. Д., & Ab, Z. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-161
de Vasconcelos, J. C., Atala, Y. B., Zantut‐Wittmann, D. E., & Parisi, M. C. R. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01328-2
“Andersen’s longitudinal study [33], carried out with 299 people with type 2 diabetes followed between 6 and 13 years, showed an association between the presence of CAN and hyperglycemia, obesity, and hyper-triglyceridemia.”
Kumlin, S. S., Kalluvya, S. E., & Mujuni, E. (2025) · OALib · doi:10.4236/oalib.1112875
Bai, M., Yan, D., Feng, R., Ran, X., Chen, D., Wang, C., Chen, L., Lin, S., He, S., Liu, Y., et al. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70109
“Previous studies have reported age, retinopathy, nephropathy, HbA1c, BMI, TG, smoking, hypertension, and polyneuropathy as predictors of impaired cardiac autonomic function in people with diabetes [31–33].”
Zografou, I., Doukelis, P., Koufakis, T., Kotzakioulafi, E., Evripidou, P., Kontoninas, Z., Savopoulos, C., Doumas, M. N., Didangelos, T., & Kantartzis, K. (2025) · Diabetology · doi:10.3390/diabetology6060055
Christensen, M. M. B., Hansen, C. S., Fleischer, J., Senftleber, N. K., Stæger, F. F., Hansen, T. F., Witte, D. R., & Jørgensen, M. E. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109179
Self-citationDavis, T. M. E., Tan, E., & Davis, W. A. (2024) · Figshare · doi:10.6084/m9.figshare.25434223
Système nerveux périphérique et neuropathie : le rôle de PCSK9
Paulo-Ramos, A. (2024) · theses.fr (ABES) · doi:10.70675/3e184b77zbe61z498fza406zcc1a7a8b5e9f
Metadata
- Authors
- Andersen, S. T., Witte, D. R., Fleischer, J., Andersen, H., Lauritzen, T., Jørgensen, M. E., Jensen, T. S., Pop-Busui, R., & Charles, M.
- Affiliations
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- University of Southern Denmark (DK)
- Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
- Corresponding author
- Andersen, Signe T.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-10-10
- Volume
- 41
- Issue
- 12
- Pages
- 2586-2594
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2895929992
- Cited by
- 99
- References
- 35
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 13 · 2023: 16 · 2022: 13 · 2021: 17 · 2020: 11 · 2019: 12
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Steno Diabetes Center Copenhagen (SDCC 3. B Epidemiology)
- Novo Nordisk Fonden (NNF14OC0011633, NNF14OC0008981)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- cardiac autonomic neuropathy, type 2 diabetes, cardiometabolic risk factors, cardiovascular autonomic reflex tests, heart rate variability, HbA1c, hyperglycemia, obesity, body mass index, hypertriglyceridemia, disease progression
- MeSH terms
- Aged, Autonomic Nervous System Diseases, Cardiovascular Diseases, Denmark, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Neuropathies, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Obesity, Risk Factors, Prevalence, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.